Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis
Status:
Unknown status
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The principle research question is: in patients with acute ischaemic stroke eligible for
intravenous (IV) thrombolysis, is tenecteplase superior in efficacy to alteplase, based on
functional outcome as assessed by modified Rankin Scale distribution at day 90?
Phase:
Phase 3
Details
Lead Sponsor:
NHS Greater Glasgow and Clyde
Collaborators:
Oxford University Hospitals NHS Trust University of Edinburgh University of Glasgow